Development of a novel shared decision making aid for primary immunodeficiency diseases.

Autor: Tzivelekis S; Takeda, 650 East Kendall Street, Cambridge, MA 02142, USA., Orange J; Columbia University Irving Medical Center, 632 W168th Street, New York, NY 10032, USA., Poulos C; RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA., Meckley LM; Takeda, 650 East Kendall Street, Cambridge, MA 02142, USA., Peay H; RTI International, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA., Sutphin J; Duke Clinical Research Institute, Duke University, 200 Morris Street, Durham NC 27705-3976, USA.; RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA., Hernandez-Trujillo VP; Allergy & Immunology Care Center of South Florida, 16371 NW 67th Ave, Miami Lakes, FL 33014, USA., Wasserman RL; Allergy Partners of North Texas, Suite B-332, 7777 Forest Lane, Dallas, TX 75230, USA.

Publikováno v: Immunotherapy [Immunotherapy] 2023 Jun; Vol. 15 (9), pp. 647-656. Date of Electronic Publication: 2023 May 09.

Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and thrombotic thrombocytopenic purpura presented at the 29th congress of the International Society on Thrombosis and Haemostasis (ISTH 2021, Jul 17-21; virtual congress).

Autor: Jain N; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Oldenburg J; Institute for Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany., Ozelo MC; Hemocentro UNICAMP, Department of Internal Medicine, School of Medical Sciences, University of Campinas, São Paulo, Brazil., Sun SX; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Tang L; Takeda Pharmaceuticals International AG, Zürich, Switzerland., Tzivelekis S; Takeda Development Center Americas, Inc., Cambridge, MA, USA.

Publikováno v: Expert review of hematology [Expert Rev Hematol] 2022 May; Vol. 15 (sup1), pp. 1-18. Date of Electronic Publication: 2022 Jun 24.

Infusion parameters, safety, and practical guidance for the manual administration of subcutaneous immunoglobulin 20% (Ig20Gly).

Autor: Grosse-Kreul, Dorothea¹ (AUTHOR) d.grosse-kreul@nhs.net, Allen, Crystal^2,3,4 (AUTHOR), Kalicinsky, Chrystyna⁵ (AUTHOR), Keith, Paul K.⁶ (AUTHOR)

Publikováno v: Allergy, Asthma & Clinical Immunology. 10/4/2024, Vol. 20 Issue 1, p1-12. 12p.

A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants.

Autor: Monleón Bonet C; Global Evidence and Outcomes, Immunology, Takeda Pharmaceuticals International AG , Zurich, Switzerland., Waser N; Real World Evidence Strategy and Analytics, ICON Plc , Vancouver, Canada., Cheng K; formerly in Global Medical Affairs, Rare Immunology, Takeda Pharmaceuticals International AG , Zurich, Switzerland., Tzivelekis S; Global Evidence & Outcomes Hematology, Takeda , Cambridge, MA., Edgar JDM; Department of Immunology, St James's Hospital and Trinity College Dublin , Dublin, Ireland., Sánchez-Ramón S; Departmento de Inmunologia Clinica, Hospital Clinico San Carlos and Universidad Complutense of Madrid , Madrid, Spain.

Publikováno v: Expert review of clinical immunology [Expert Rev Clin Immunol] 2020 Sep; Vol. 16 (9), pp. 911-921. Date of Electronic Publication: 2020 Nov 21.

Understanding Gastric GIST: From Pathophysiology to Personalized Treatment.

Autor: Moga, Doru-Florian-Cornel^1,2 (AUTHOR) cornel.moga@ulbsibiu.ro, Vlădoiu, Gabriela^2,3 (AUTHOR) catanamariagabriela@gmail.com, Frățilă, Anca-Maria^2,4 (AUTHOR) catanamariagabriela@gmail.com, Dan, Andreea-Alina⁵ (AUTHOR) at-radiologie@spitalmilitarsb.ro, Popa, Daniel⁶ (AUTHOR) danieliulian.popa@ulbsibiu.ro, Oprea, Valentin^7,8 (AUTHOR) opreasv31@gmail.com

Publikováno v: Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p3997. 17p.